All Stories

Pfizer, BioNTech notch US win—and loss in Germany—amid high-stakes patent fight with Moderna

Moderna sued Pfizer and BioNTech over three patents protecting its COVID-19 work back in 2022. Now, a U.S. administrative body has ruled that two of those patents are invalid.

Mar 6, 2025 - 16:59
 0
Pfizer, BioNTech notch US win—and loss in Germany—amid high-stakes patent fight with Moderna
Moderna sued Pfizer and BioNTech over three patents protecting its COVID-19 work back in 2022. Now, a U.S. administrative body has ruled that two of those patents are invalid.
Read More

Tags:

Previous Article

U.S. Hotel Industry Witnesses Positive Growth in Late February, CoStar Reports

Next Article

Suniva, Heliene and Corning collaborate on US-made solar modules

Related Posts

Roche nabs FDA nod for Evrysdi tablets, bolstering convenience edge over rivals

Roche nabs FDA nod for Evrysdi tablets, bolstering conv...

Feb 12, 2025  0

Roche, Gilead top patient groups' rankings of pharma ESG practices

Roche, Gilead top patient groups' rankings of pharma ES...

Feb 28, 2025  0

Merck KGaA sets its sights on acquisition of Ogsiveo-maker SpringWorks: Reuters

Merck KGaA sets its sights on acquisition of Ogsiveo-ma...

Feb 10, 2025  0